iSpecimen Inc.

NasdaqCM:ISPC Stock Report

Market Cap: US$2.8m

iSpecimen Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Robert Lim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Jan 01
iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

iSpecimen Inc. (NASDAQ:ISPC) Might Not Be As Mispriced As It Looks After Plunging 32%

Sep 13
iSpecimen Inc. (NASDAQ:ISPC) Might Not Be As Mispriced As It Looks After Plunging 32%

US$3.00: That's What Analysts Think iSpecimen Inc. (NASDAQ:ISPC) Is Worth After Its Latest Results

Aug 09
US$3.00: That's What Analysts Think iSpecimen Inc. (NASDAQ:ISPC) Is Worth After Its Latest Results

Take Care Before Diving Into The Deep End On iSpecimen Inc. (NASDAQ:ISPC)

Jan 04
Take Care Before Diving Into The Deep End On iSpecimen Inc. (NASDAQ:ISPC)

Downgrade: Here's How This Analyst Sees iSpecimen Inc. (NASDAQ:ISPC) Performing In The Near Term

Aug 07
Downgrade: Here's How This Analyst Sees iSpecimen Inc. (NASDAQ:ISPC) Performing In The Near Term

Investors Still Aren't Entirely Convinced By iSpecimen Inc.'s (NASDAQ:ISPC) Revenues Despite 33% Price Jump

Apr 18
Investors Still Aren't Entirely Convinced By iSpecimen Inc.'s (NASDAQ:ISPC) Revenues Despite 33% Price Jump

iSpecimen names finance chief Tracy Curley as interim CEO

Sep 22

iSpecimen Inc. (NASDAQ:ISPC) Analysts Just Slashed This Year's Estimates

Aug 10
iSpecimen Inc. (NASDAQ:ISPC) Analysts Just Slashed This Year's Estimates

iSpecimen GAAP EPS of -$0.30 misses by $0.02, revenue of $2.3M misses by $0.55M

Aug 04

iSpecimen Inc.'s (NASDAQ:ISPC) Intrinsic Value Is Potentially 69% Above Its Share Price

Mar 31
iSpecimen Inc.'s (NASDAQ:ISPC) Intrinsic Value Is Potentially 69% Above Its Share Price

iSpecimen: High Growth Marketplace At A Discount

Jul 07

iSpecimen raises $18M via Nasdaq IPO

Jun 21

CEO

Robert Lim (30 yo)

less than a year

Tenure

Mr. Robert Bradley Lim is CEO & Director of iSpecimen Inc. from December 9, 2024 and serves as its Treasurer and Secretary since December 27, 2024. Mr. Lim is Independent Director of Qualigen Therapeutics,...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Lim
CEO, Treasurerless than a yearno datano data
Yuying Liang
Chief Financial Officerless than a yearno datano data
Leslie Hoyt
Senior Vice President of Operationsno datano datano data
Carly Lejnieks
Vice President of Marketingno datano datano data
Annette Arnold
Vice President of Sales & Business Development2yrsno datano data

0.08yrs

Average Tenure

Experienced Management: ISPC's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Robert Lim
CEO, Treasurerless than a yearno datano data
John Brooks
Independent Director3.6yrsUS$34.93k0.017%
$ 472.6
Avtar Dhaliwal
Independent Directorless than a yearno datano data
Richard Paolone
Directorless than a yearno datano data
Katharyn Field
Independent Chairman of the Boardless than a yearno datano data

0.3yrs

Average Tenure

34yo

Average Age

Experienced Board: ISPC's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 00:15
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

iSpecimen Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew HewittCraig-Hallum Capital Group LLC
Constantine DavidesD. Boral Capital LLC.
Ashok KumarThinkEquity LLC